Literature DB >> 15155250

Successful use of voriconazole for treatment of Coccidioides meningitis.

Laurie A Proia, Allan R Tenorio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155250      PMCID: PMC415562          DOI: 10.1128/AAC.48.6.2341.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

1.  In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.

Authors:  R K Li; M A Ciblak; N Nordoff; L Pasarell; D W Warnock; M R McGinnis
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis.

Authors:  M C Fisher; G L Koenig; T J White; J W Taylor
Journal:  Mycologia       Date:  2002 Jan-Feb       Impact factor: 2.696

Review 3.  Voriconazole: a new triazole antifungal agent.

Authors:  Leonard B Johnson; Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2003-02-10       Impact factor: 9.079

4.  Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?

Authors:  D H Dewsnup; J N Galgiani; J R Graybill; M Diaz; A Rendon; G A Cloud; D A Stevens
Journal:  Ann Intern Med       Date:  1996-02-01       Impact factor: 25.391

5.  Successful treatment of coccidioidal meningitis with voriconazole.

Authors:  Karoll J Cortez; Thomas J Walsh; John E Bennett
Journal:  Clin Infect Dis       Date:  2003-06-09       Impact factor: 9.079

  5 in total
  15 in total

1.  The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.

Authors:  S Schwartz; A Reisman; P F Troke
Journal:  Infection       Date:  2011-04-22       Impact factor: 3.553

2.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

3.  Successful use of combination antifungal therapy in the treatment of coccidioides meningitis.

Authors:  Suresh J Antony; Peter Jurczyk; Lisa Brumble
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

Review 4.  Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.

Authors:  Chinh Nguyen; Bridget Marie Barker; Susan Hoover; David E Nix; Neil M Ampel; Jeffrey A Frelinger; Marc J Orbach; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

5.  In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil.

Authors:  R A Cordeiro; R S N Brilhante; M F G Rocha; M A B Fechine; A K F Costa; Z P Camargo; J J C Sidrim
Journal:  Mycopathologia       Date:  2006-01       Impact factor: 2.574

6.  The role of second-generation antifungal triazoles for treatment of the endemic mycoses.

Authors:  Alison G Freifeld; J Ryan Bariola; David Andes
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

7.  Voriconazole use for endemic fungal infections.

Authors:  Alison Freifeld; Laurie Proia; David Andes; Larry M Baddour; Janis Blair; Brad Spellberg; Sandra Arnold; Arnold Lentnek; L Joseph Wheat
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

8.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

9.  Coccidioidal meningitis: update on epidemiology, clinical features, diagnosis, and management.

Authors:  Janis E Blair
Journal:  Curr Infect Dis Rep       Date:  2009-07       Impact factor: 3.725

10.  Coccidioidomycosis: Epidemiology, Fungal Pathogenesis, and Therapeutic Development.

Authors:  Hazael Hernandez; Victor H Erives; Luis R Martinez
Journal:  Curr Trop Med Rep       Date:  2019-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.